PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Epidemiology and Biostatistics, Key Laboratory for Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan 430030, China.\', \'Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, China.\', \'Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.\', \'Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; and.\', \'Department of Respiratory and Critical Care Medicine, Wuhan Pulmonary Hospital, Wuhan 430030, China.\', \'Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan 430060, China; huke-rmhospital@163.com miaoxp@hust.edu.cn huilanz_76@163.com.\', \'Department of Epidemiology and Biostatistics, Key Laboratory for Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Sciences and Technology, Wuhan 430030, China; huke-rmhospital@163.com miaoxp@hust.edu.cn huilanz_76@163.com.\', \'Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; huke-rmhospital@163.com miaoxp@hust.edu.cn huilanz_76@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.4049/jimmunol.2000981
?:hasPublicationType
?:journal
  • Journal of immunology (Baltimore, Md. : 1950)
is ?:pmid of
?:pmid
?:pmid
  • 33298617
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Repurposed Tocilizumab in Patients with Severe COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all